Evidence map›Paper›PMID 28238460›Full record

GuidelineAtencion primaria2017

[Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)].

F Mearin, C Ciriza, M Mínguez, E Rey, J J Mascort, E Peña, P Cañones, J Júdez, en nombre de la SEPD, la semFYC, la SEMERGEN y la SEMG

Open access · goldAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Atencion primaria, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Acupoint Massage Therapy Alters the Composition of Gut Microbiome in Functional Constipation Patients.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

F MearinCoordinación de la GPC, Comité Roma de Trastornos Funcionales Intestinales, Asociación Española de Gastroenterología (AEG), Centro Médico Teknon, Barcelona, España.
C CirizaGrupo de Trastornos Funcionales, Sociedad Española de Patología Digestiva (SEPD), Hospital Universitario Doce de Octubre, Madrid, España.
M MínguezAEG y SEPD, Hospital Clínico Universitario, Universitat de Valencia, Valencia, España.
E ReySEPD, Hospital Clínico Universitario San Carlos, Madrid, España.
J J MascortSecretaría Científica, Sociedad Española de Medicina de Familia y Comunitaria (semFYC), España. Electronic address: jmascort@semfyc.es.
E PeñaCoordinación de Digestivo, Sociedad Española de Médicos de Atención Primaria (SEMERGEN), España.
P CañonesCoordinación de Digestivo, Sociedad Española de Médicos Generales y de Familia (SEMG), España.
J JúdezDepartamento de Gestión del Conocimiento, SEPD, España.
en nombre de la SEPD, la semFYC, la SEMERGEN y la SEMG
Sociedad Española de Medicina Interna · ESAsociación Española de Urología · ESHospital Clínico San Carlos · ESHospital Clínico Universitario de Valencia · ESSociedad Española de Patología Digestiva · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this Clinical practice guide we examine the diagnostic and therapeutic management of adult patients with constipation and abdominal discomfort, at the confluence of the spectrum of irritable bowel syndrome and functional constipation. Both fall within the framework of functional intestinal disorders and have major personal, health and social impact, altering the quality of life of the patients affected. The former is a subtype of irritable bowel syndrome in which constipation and altered bowel habit predominate, often along with recurring abdominal pain, bloating and abdominal distension. Constipation is characterised by infrequent or hard-to-pass bowel movements, often accompanied by straining during defecation or the sensation of incomplete evacuation. There is no underlying organic cause in the majority of cases; it being considered a functional bowel disorder. There are many clinical and pathophysiological similarities between the two conditions, the constipation responds in a similar way to commonly used drugs, the fundamental difference being the presence or absence of pain, but not in an "all or nothing" way. The severity of these disorders depends not only on the intensity of the intestinal symptoms but also on other biopsychosocial factors: association of gastrointestinal and extraintestinal symptoms, degree of involvement, forms of perception and behaviour. Functional bowel disorders are diagnosed using the Rome criteria. This Clinical practice guide adapts to the Rome IV criteria published at the end of May 2016. The first part (96, 97, 98) examined the conceptual and pathophysiological aspects, alarm criteria, diagnostic test and referral criteria between Primary Care and Gastroenterology. This second part reviews all the available treatment alternatives (exercise, fluid ingestion, diet with soluble fibre-rich foods, fibre supplements, other dietary components, osmotic or stimulating laxatives, probiotics, antibiotics, spasmolytics, peppermint essence, prucalopride, linaclotide, lubiprostone, biofeedback, antdepressants, psychological treatment, acupuncture, enemas, sacral root neurostimulation and surgery), and practical recommendations are made for each.

Indexed as

AdultAlgorithmsConstipationHumansIrritable Bowel SyndromeAbdominal discomfortAdultosAdultsAtención PrimariaClinical practice guideDigestive diseasesEnfermedades digestivasEstreñimiento funcionalFunctional constipationGuía de práctica clínicaIrritable bowel syndromeMolestia abdominalPrimary careRoma IVRome IVSíndrome del intestino irritable

Identifiers

PMID28238460
PMCPMC6875999
OpenAlexW2589970041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.